Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Rhomberg, Paul R.
and
Jones, Ronald N.
2009.
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008).
Diagnostic Microbiology and Infectious Disease,
Vol. 65,
Issue. 4,
p.
414.
Curcio, Daniel
Barcelona, Laura I.
Cornistein, Wanda
Bantar, Carlos
Barcan, Laura
Bonvehí, Pablo
Reina, Rosa
Bergallo, Carlos
Biondi, Héctor
Calderón, Jorge
Castagnino, Jorge
Chinchilla, Paulo
Dignani, María Cecilia
Esposto, Amadeo
Pérez, Norma Falcón
Freuler, Cristina
Luna, Carlos M.
Ríos, Fernando
Rodriguez, Claudia
valentini, Ricardo
Vazquez, Walter
verbanaz, Sergio
and
vergara, Gabriel
2009.
Current Rational to Prescribe Tigecycline: Critical Analysis of the Evidence and Usage Algorithms by an Argentinean Experts Panel.
Clinical Medicine. Therapeutics,
Vol. 1,
Issue. ,
p.
CMT.S3312.
Bulik, Catharine C.
Christensen, Henry
Li, Peng
Sutherland, Christina A.
Nicolau, David P.
and
Kuti, Joseph L.
2010.
Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against
Klebsiella pneumoniae
Producing the KPC Carbapenemase versus That against
Pseudomonas aeruginosa
in an
In Vitro
Pharmacodynamic Model
.
Antimicrobial Agents and Chemotherapy,
Vol. 54,
Issue. 2,
p.
804.
Cuzon, G.
Naas, T.
and
Nordmann, P.
2010.
Carbapénèmases de type KPC : quel enjeu en microbiologie clinique ?.
Pathologie Biologie,
Vol. 58,
Issue. 1,
p.
39.
Michalopoulos, Argyris S
and
Karatza, Dimitra C
2010.
Multidrug-resistant Gram-negative infections: the use of colistin.
Expert Review of Anti-infective Therapy,
Vol. 8,
Issue. 9,
p.
1009.
Daikos, G. L.
Vryonis, E.
Psichogiou, M.
Tzouvelekis, L. S.
Liatis, S.
Petrikkos, P.
Kosmidis, C.
Tassios, P. T.
Bamias, G.
and
Skoutelis, A.
2010.
Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo- -lactamase.
Journal of Antimicrobial Chemotherapy,
Vol. 65,
Issue. 4,
p.
784.
Kaye, Keith S.
Auwaerter, Paul
Bosso, John A.
Dean, Nathan C.
Doern, Gary V.
Kays, Michael B.
Pogue, Jason M.
Ritchie, David J.
and
Wispelwey, Brian
2010.
Strategies to Address Appropriate Fluoroquinolone Use in the Hospital.
Hospital Pharmacy,
Vol. 45,
Issue. 11,
p.
844.
Maragakis, Lisa L.
2010.
Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit.
Critical Care Medicine,
Vol. 38,
Issue. ,
p.
S345.
Bilavsky, Efraim
Schwaber, Mitchell J
and
Carmeli, Yehuda
2010.
How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies.
Current Opinion in Infectious Diseases,
Vol. 23,
Issue. 4,
p.
327.
Hyle, E. P.
Ferraro, M. J.
Silver, M.
Lee, H.
and
Hooper, D. C.
2010.
Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes.
Infection Control & Hospital Epidemiology,
Vol. 31,
Issue. 12,
p.
1242.
Mouloudi, Eleni
Protonotariou, Euthymia
Zagorianou, Alexia
Iosifidis, Elias
Karapanagiotou, Areti
Giasnetsova, Tatiana
Tsioka, Agoritsa
Roilides, Emmanuel
Sofianou, Danai
and
Gritsi-Gerogianni, Nikoleta
2010.
Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes.
Infection Control & Hospital Epidemiology,
Vol. 31,
Issue. 12,
p.
1250.
Leavitt, Azita
Carmeli, Yehuda
Chmelnitsky, Inna
Goren, Moran G.
Ofek, Itzhak
and
Navon-Venezia, Shiri
2010.
Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing
Klebsiella pneumoniae
Strains in Israel
.
Antimicrobial Agents and Chemotherapy,
Vol. 54,
Issue. 7,
p.
3002.
Geffen, Y.
Finkelstein, R.
Oren, I.
Shalaginov, R.
Tavleva, I.
and
Sprecher, H.
2010.
Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae.
Journal of Hospital Infection,
Vol. 76,
Issue. 4,
p.
355.
Bulik, Catharine C.
and
Nicolau, David P.
2011.
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy,
Vol. 55,
Issue. 6,
p.
3002.
Zuckerman, T
Benyamini, N
Sprecher, H
Fineman, R
Finkelstein, R
Rowe, J M
and
Oren, I
2011.
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Bone Marrow Transplantation,
Vol. 46,
Issue. 9,
p.
1226.
Yang, Jiyong
Luo, Yanping
Cui, Shenghui
Wang, Weiwei
and
Han, Li
2011.
Diverse Phenotypic and Genotypic Characterization Among ClinicalKlebsiella pneumoniaeandEscherichia coliIsolates Carrying Plasmid-Mediated Quinolone Resistance Determinants.
Microbial Drug Resistance,
Vol. 17,
Issue. 3,
p.
363.
Kritsotakis, E. I.
Tsioutis, C.
Roumbelaki, M.
Christidou, A.
and
Gikas, A.
2011.
Antibiotic use and the risk of carbapenem-resistant extended-spectrum- -lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
Journal of Antimicrobial Chemotherapy,
Vol. 66,
Issue. 6,
p.
1383.
Mills, John
Chapin, Kimberle
Andrea, Sarah
Furtado, Gary
and
Mermel, Leonard
2011.
Community and Nursing Home Residents with Carbapenemase-Producing Klebsiella pneumoniae Infection.
Infection Control & Hospital Epidemiology,
Vol. 32,
Issue. 6,
p.
629.
Chang, Hong-Jyun
Hsu, Po-Chang
Yang, Chien-Chang
Kuo, An-Jing
Chia, Ju-Hsin
Wu, Tsu-Lan
and
Lee, Ming-Hsun
2011.
Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: A matched case–control study.
Journal of Microbiology, Immunology and Infection,
Vol. 44,
Issue. 2,
p.
125.
Patel, Gopi
and
Bonomo, Robert A
2011.
Status report on carbapenemases: challenges and prospects.
Expert Review of Anti-infective Therapy,
Vol. 9,
Issue. 5,
p.
555.